Literature DB >> 14674935

Lack of association of HLA class I genes and TNF alpha-308 polymorphism in toluene diisocyanate-induced asthma.

B Beghé1, M Padoan, C T Moss, S J Barton, J W Holloway, S T Holgate, W M Howell, C E Mapp.   

Abstract

BACKGROUND: Toluene diisocyanate (TDI)-induced asthma is a common cause of occupational asthma and it affects 5-15% of the exposed population suggesting an underlying genetic susceptibility.
METHODS: To investigate the role of genetic factors in the development of TDI-induced asthma, we analyzed the distribution of human leukocyte antigen (HLA) class I genes and of tumor necrosis factor (TNF)-alpha A-308G polymorphism in 142 patients with TDI-induced asthma and in 50 asymptomatic exposed subjects.
RESULTS: Neither the distribution of HLA class I antigens nor the distribution of TNF-alpha A-308G polymorphism was different between patients with TDI-induced asthma and asymptomatic exposed subjects.
CONCLUSIONS: These results suggest that HLA class I antigens and TNF-alpha A-308G are not associated with susceptibility or resistance to the development of TDI-induced asthma.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14674935     DOI: 10.1046/j.1398-9995.2003.00352.x

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  22 in total

Review 1.  Pro/Con debate: Is occupational asthma induced by isocyanates an immunoglobulin E-mediated disease?

Authors:  A V Wisnewski; M Jones
Journal:  Clin Exp Allergy       Date:  2010-06-07       Impact factor: 5.018

2.  The -308 G/A polymorphism in TNF-α gene is associated with asthma risk: an update by meta-analysis.

Authors:  Yonggang Zhang; Jie Zhang; Can Tian; Yuling Xiao; Chao He; Xiaobo Li; Amrit Bogati; Jin Huang; Hong Fan
Journal:  J Clin Immunol       Date:  2010-11-17       Impact factor: 8.317

3.  Genetic variants in TNFα, TGFB1, PTGS1 and PTGS2 genes are associated with diisocyanate-induced asthma.

Authors:  Berran Yucesoy; Michael L Kashon; Victor J Johnson; Zana L Lummus; Kara Fluharty; Denyse Gautrin; André Cartier; Louis-Philippe Boulet; Joaquin Sastre; Santiago Quirce; Susan M Tarlo; Maria-Jesus Cruz; Xavier Munoz; Michael I Luster; David I Bernstein
Journal:  J Immunotoxicol       Date:  2015-09-04       Impact factor: 3.000

4.  Influence of polymorphic metabolic enzymes on biotransformation and effects of diphenylmethane diisocyanate.

Authors:  Margareta Littorin; Saimei Hou; Karin Broberg; Jonas Björk; Susanne Fält; Galbani Abdoulaye; Malgorzata Kalemba; Charlotta Ryk; Staffan Skerfving
Journal:  Int Arch Occup Environ Health       Date:  2007-08-04       Impact factor: 3.015

Review 5.  Gene-environment interactions in asthma.

Authors:  F Castro-Giner; F Kauffmann; R de Cid; M Kogevinas
Journal:  Occup Environ Med       Date:  2006-11       Impact factor: 4.402

Review 6.  Association between polymorphism of tumour necrosis factor alpha-308 gene promoter and asthma: a meta-analysis.

Authors:  J Gao; G Shan; B Sun; P J Thompson; X Gao
Journal:  Thorax       Date:  2006-03-03       Impact factor: 9.139

Review 7.  Genetic susceptibility to occupational exposures.

Authors:  D C Christiani; A J Mehta; C-L Yu
Journal:  Occup Environ Med       Date:  2008-06       Impact factor: 4.402

Review 8.  Biological and genetic markers in occupational asthma.

Authors:  Gyu-Young Hur; Hae-Sim Park
Journal:  Curr Allergy Asthma Rep       Date:  2015-01       Impact factor: 4.806

Review 9.  Evidence based guidelines for the prevention, identification, and management of occupational asthma.

Authors:  P J Nicholson; P Cullinan; A J Newman Taylor; P S Burge; C Boyle
Journal:  Occup Environ Med       Date:  2005-05       Impact factor: 4.402

10.  Early incidence of occupational asthma among young bakers, pastry-makers and hairdressers: design of a retrospective cohort study.

Authors:  Thomas Rémen; Vincent Coevoet; Dovi-Stéphanie Acouetey; Jean-Louis Guéant; Rosa-Maria Guéant-Rodriguez; Christophe Paris; Denis Zmirou-Navier
Journal:  BMC Public Health       Date:  2010-04-26       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.